Enveric Biosciences, Inc. (ENVB) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Enveric Biosciences, Inc. in 2026. The next earnings report is expected on November 12, 2026.
Next earnings date
12 Nov 2026
In 84 days
EPS estimate
—
Revenue estimate
—
Past earnings
No dividend history available.
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Enveric Biosciences, Inc. (ENVB) is scheduled to report earnings on November 12, 2026.
Enveric Biosciences, Inc. (ENVB) last reported earnings on August 14, 2026.
Enveric Biosciences, Inc. (ENVB) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.